MEPSGEN

The Scalable Particle Production System

Seamless Scale-Up from Discovery to GMP Manufacturing

MORE
The All-in-One Robotic Solution for Microphysiological System Modeling

MORE
The Human Microphysiological Systems Platform

Human-Relevant Tissue Modeling with Versatile Chip Designs

MORE

: PRODUCT LINES
BROCHURE : ProMEPS^®

More More

: PRODUCT LINES
BROCHURE : MEPS-X series

More More

: PRODUCT LINES
BROCHURE : NanoCalibur^®

More More

TECHNOLOGY

Innovative Micro & Nano Platforms for drug development

MICROPHYSIOLOGICAL SYSTEM MEPS-X series

MICROVORTEX SYSTEM MST-X series

NANOMEDICINE MG-X series

MEPS-X series: Manufactured 3D MPS Chip Platform

MST-X series: Scalable Production of Lipid Nanoparticles

MG-X series: Nanoparticle Drug Delivery System

MEDIA

: MEPSGEN to Showcase Next-Generation MPS and DDS Platforms at BIO USA
2026.06.15

: MEPSGEN Partners with Imperial College London to Co-Develop IBD Model
2026.05.29

: MEPSGEN Highlights Its Automated MPS Modeling System at MPS World Summit 2026
2026.05.22

: HLB Pharmaceutical Joins Hands with MEPSGEN to Strengthen Competitiveness in Next-Generation Drug Delivery Technologies
2026.04.28

: MEPSGEN Accelerates Large-Scale Microparticle Production for Long-Acting Injectable Formulations
2026.04.27

: MEPSGEN Selected as a ‘2026 Global IP Star Company’ by the Korean Intellectual Property Office (KIPO)
2026.04.21

: MEPSGEN partners with Imperial College London’s newly established 'Centre for Intestinal Systems'
2026.01.16

: MEPSGEN Awarded the Presidential Citation at the 2025 Venture Entrepreneurship Awards
2025.12.11

: MEPSGEN partners with Sungkyunkwan University to develop glioblastoma tumor microenvironment model
2025.11.04